To evaluate the function of cysteine residues of the Src kinase, we constructed a series of Src mutants in which some of cyteines were replaced to alanines. With these mutants, we studied the effect of SH-alkylating agents, N-[p-(2-benzimidazolyl)phenyl] maleimide (BIPM) and N-(9-acridinyl) maleimide (NAM), on their kinase activity. Of 10 cysteine residues scattered over v-Src, either a single mutation at Cys520 or multiple mutations at the four clustered cyteines, Cys483, Cys487, Cys496 and Cys498, yielded clear resistance to the treatment with 10 lm BIPM or 1 lm NAM. In contrast, other cysteines including those in the SH2 domain and those in the catalytic cleft of the kinase domain were dispensable for the inactivation by BIPM and NAM. Similarly, deletion of SH2 and SH3 did not confer the resistance to v-Src, suggesting the inactivation by the SH-alkylating agents is SH2/SH3-independent. Although Cys520-mutated v-Src was resistant to 1 lm NAM, it was inactivated by 5 lm NAM. However, combined mutation including all of Cys483, Cys487, Cys496, Cys498 and Cys520 yielded clear resistance to 5 lm NAM. Among these mutants, those with double mutations in the four clustered cysteines yielded a temperature sensitive phenotype in the transfected cells, whereas Cys520 did not, suggesting that Cys520 has, at least in part, a discrete function. In contrast to v-Src, c-Src, which lacks cysteine at position 520, was resistant to 1 lm NAM but sensitive to 5 lm NAM. While replacement of Phe520 of c-Src to cysteine made it sensitive to 1 lm NAM, double mutation in clustered cysteines again yielded resistance to 5 lm NAM. Taken together, our results strongly suggest that the multiple cysteine residues clustered at the end of the Cterminal lobe are critical for the inhibition by the SHalkylating agents and, thereby, have an allosteric repressor effect on the catalytic activity of Src in a SH2-phosphoTyr527 independent manner.
To evaluate the function of cysteine residues of the Src kinase, we constructed a series of Src mutants in which some of cyteines were replaced to alanines. With these mutants, we studied the effect of SH-alkylating agents, N-[p-(2-benzimidazolyl)phenyl] maleimide (BIPM) and N-(9-acridinyl) maleimide (NAM), on their kinase activity. Of 10 cysteine residues scattered over v-Src, either a single mutation at Cys520 or multiple mutations at the four clustered cyteines, Cys483, Cys487, Cys496 and Cys498, yielded clear resistance to the treatment with 10 lm BIPM or 1 lm NAM. In contrast, other cysteines including those in the SH2 domain and those in the catalytic cleft of the kinase domain were dispensable for the inactivation by BIPM and NAM. Similarly, deletion of SH2 and SH3 did not confer the resistance to v-Src, suggesting the inactivation by the SH-alkylating agents is SH2/SH3-independent. Although Cys520-mutated v-Src was resistant to 1 lm NAM, it was inactivated by 5 lm NAM. However, combined mutation including all of Cys483, Cys487, Cys496, Cys498 and Cys520 yielded clear resistance to 5 lm NAM. Among these mutants, those with double mutations in the four clustered cysteines yielded a temperature sensitive phenotype in the transfected cells, whereas Cys520 did not, suggesting that Cys520 has, at least in part, a discrete function. In contrast to v-Src, c-Src, which lacks cysteine at position 520, was resistant to 1 lm NAM but sensitive to 5 lm NAM. While replacement of Phe520 of c-Src to cysteine made it sensitive to 1 lm NAM, double mutation in clustered cysteines again yielded resistance to 5 lm NAM. Taken together, our results strongly suggest that the multiple cysteine residues clustered at the end of the Cterminal lobe are critical for the inhibition by the SHalkylating agents and, thereby, have an allosteric repressor effect on the catalytic activity of Src in a SH2-phosphoTyr527 independent manner. Oncogene (2003) 22, 1411-1417. doi:10.1038/sj.onc.1206286 Keywords: Src; SH-alkylating agents; inactivation; cysteine; redox The oncogene product of Rous sarcoma virus, the v-Src kinase, and its cellular counterpart, the c-Src kinase, are both membrane-bound tyrosine protein kinases (Martin, 2001 ). While v-Src is highly oncogenic, c-Src is inactive in transformation (Iba et al., 1984) . In their Nterminus halves, both Src proteins have domains called SH3, which can bind short proline-rich peptide motifs, and SH2 which can bind to phosphotyrosine residues (Cooper and Howell, 1993; Pawson, 1995; Martin, 2001) . Intramolecular bindings of SH2 to phosphorylated Tyr527, which is unique to c-Src, and of SH3 to the linker region appear to fold the c-Src molecule to be a closed and inactive state (Cooper and Howell, 1993; Superti-Furga et al., 1993; Sicheri and Kuriyan, 1997; Xu et al., 1997) . Thus, any mutations including a point mutation at Tyr527 that unfold the structure can convert c-Src to be active and highly oncogenic (Cooper and Howell, 1993; Martin, 2001) .
In addition to Tyr527-based regulation of c-Src, accumulated evidence suggests that Src has another regulatory mechanism based on the modification of its cysteine residues (Fukazawa et al., 1990; Pu et al., 1996; Senga et al., 2000) . The SH-alkylating agents could inactivate v-Src kinase (Fukazawa et al., 1990) , whereas mercuric ions, which react with sulfhydryl groups of protein in an exceptionally high association constant (Stricks and Kolthoff, 1953; Simpson, 1961) , could directly activate c-Src and this activation was blocked by N-acetylcysteine (Pu et al., 1996) . Similarly, nitric oxide could directly activate c-Src through a sulfhydryl group modification (Akhand et al., 1999) . These observations suggest the importance of cysteine residues in Src kinase regulation. However, it is of interest that both the inactivation by the SH-alkylating agents and the activation by mercuric ions and nitric oxide involve the modification of sulfhydryl groups of Src protein. It might be possible that some of the cysteine residues in Src are involved in the kinase activation, whereas others are required for the inactivation. Despite the importance, the role of the cyteine residues scattered over the Src kinase remains largely unclear. As a step to explore the cysteine residues of Src functionally important for the inactivation of the kinase activity, we constructed a series of mutant Src proteins whose cysteine residues were replaced with alanine. With these mutant Src proteins, we examined the effect of the SH-alkylating agents on the kinase activity. The SH-alkylating agents such as N-[p-(2-benzimidazolyl)phenyl] maleimide (BIPM) and N-(9-acridinyl) maleimide (NAM) could inactivate v-Src kinase (Fukazawa et al., 1990) , but its mechanism remains unclear. In this paper, we show, for the first time, that among multiple cysteines scattered over the Src molecule, those localized in the cysteineclustered (CC) motif, Cys483, Cys487, Cys496 and Cys498, and another one, Cys520, that is unique for v-Src, are important for the inactivation by these SH-alkylating agents. In contrast, other cysteine residues including those in the catalytic cleft of the kinase domain and those in the SH2 domain are dispensable for the inactivation by the SH-alkylating agents. Figure 1 shows the summary of the positions of cysteine residues in Src and other tyrosine kinases. Of 10 cysteine residues that scattered over the v-Src protein, three of them, Cys185, Cys238 and Cys245, are located in the SH2 domain, and two of them, Cys277 and Cys400, are in the catalytic cleft of the kinase domain. Four cysteines, Cys483, Cys487, Cys496 and Cys498, form a cluster at the base of the C-terminal lobe of the kinase domain. Since these four cysteine residues are located closely each other to form a cluster and highly conserved among multiple tyrosine kinases (Veillette et al., 1993; Senga et al., 2000) , we call the amino-acid sequence from Cys483 to Trp499 as the clustered cysteine (CC) motif. These nine cysteine residues are conserved also in c-Src. In addition to these nine cysteine residues, v-Src, but not other tyrosine kinases, has another cysteine, Cys520, in the end of C-terminal lobe leading to the C-terminal tail ( Figure 1 ). Of these cysteine residues, Cys238 and Cys245 in the SH2 domain, Cys400 in the catalytic cleft, and Cys487 and Cys498 in the CC motif are highly conserved among the Src family protein tyrosine kinases (Figure 1) .
To assess the role of each cysteine residue of v-Src, a series of mutant v-Src in which each one of the cysteine residues was replaced to alanine were constructed by site-directed mutagenesis (Senga et al., 2000) . These mutant v-src genes with a single point mutation at one of the cysteines were named as C1A (mutated in Cys185), C2A (Cys238), C3A (Cys245), C4A (Cys277), C5A (Cys400), C6A (Cys483), C7A (Cys487), C8A (Cys496), C9A (Cys498) and C10A (Cys520). These mutant genes were ligated into pcDNA3 vector, reconfirmed the mutations by sequencing and transiently expressed in Cos7 cells.
We first studied the first three mutants, C1A, C2A and C3A, which have mutation in the SH2 domain. These mutant v-Src proteins were immunoprecipitated and their in vitro kinase activity and sensitivity to the SH-alkylating agents, NAM and BIPM, were assayed with casein or enolase as an exogenous substrate ( Figure 2a ) (Hamaguchi and Hanafusa, 1987; Hamaguchi et al., 1993) . Relative amounts of Src proteins Figure 1 The primary sequences and secondary-structural alignment of the Src-family kinases in comparison with v-Src and focusing on cysteine residues. Sequence text was constructed focusing on cysteine residues of v-Src based on the results from Clustalw analysis, DDBJ Homology Search System, PSI-BLAST (Altschul et al., 1997) and GENETYX. Accession numbers in Entrez Protein Sequence Search for each kinases are as follows. v-Src (AAA42563.1); c-Src (AAA70194.1) (AAA60584) (AAA40135); Yes (CAA31595) (AAA35735) (CAA47909); Yrk (CAA47996); Fyn (CAA37025) (AAH32149) (NP-002028); Lyn (AAA59540) (AAA39470); Lck (AAA59502) (XP-110515) (P42683); Blk (AAB33265) (AAA40453); Hck (AAA52643) (CAA68544); Frk (P42685) (I49552); Fgr (P09769) (CAA34463). H represents Human, C is chicken and M is mouse. Secondary-structural alignment given above the sequences was based on previous reports (Xu et al., 1997; Sicheri and Kuriyan, 1997) . Cysteine residues at positions 235, 245, 400, 487 and 498 are highly conserved among the Src family kinases. Phenylalanine at position 520 is also highly conserved in all the Src family kinases except for v-Src were normalized by immunoblotting with anti-Src as previously reported (Hamaguchi and Hanafusa, 1987; Hamaguchi et al., 1993) and same amounts of Src proteins were used throughout the study (data not shown). We confirmed that either 10 mm BIPM or 1 mm NAM was sufficient to inhibit the in vitro kinase activity of wild-type v-Src as previously reported (Fukazawa et al., 1990) . We found that both NAM and BIPM could suppress the kinase activities of these mutants to the levels similar to those of wild-type v-Src. These results suggest that cysteine residues localized in the SH2 domain are not critical for the inhibition of the kinase activity by the SH-alkylating agents.
To confirm and extend these observations, we next constructed a mutant v-Src, DSH2/SH3v-Src, in which both SH2 and SH3 were deleted. We found that the catalytic activity of DSH2/SH3v-Src was sensitive to the SH-alkylating agents to the levels similar to those of wild-type v-Src (Figure 2b ). These results suggest that cyteine residues critical for the inhibition by the SHalkylating agents may be localized in the kinase domain.
We next analysed the role of Cys277 and Cys400 localized in the catalytic cleft. Cys277 is located in the connection between the b1 and b2 sheets that form a tip of the N-terminal lobe protruding to form the catalytic cleft, whereas Cys400 is in the b8 sheet that is localized deeply in the bottom of the catalytic cleft (Xu et al., 1997) . As shown in Figure 2c , mutant v-Src proteins, C4Av-src and C5Av-src which have point mutation at Cys277 and Cys400, respectively, were active in their kinase and sensitive to the SH-alkylating reagents to the levels similar to those of wild-type v-Src. These results Figure 2 Effect of the SH-alkylating agents on the kinase activities of v-Src and v-Src mutants which lack cysteine residues in the SH2 domain or in the catalytic cleft. (a) Wild-type v-src and mutant v-src (C1A, C2A and C3A) in pcDNA 3 (5 mg of each) were transiently expressed in COS 7 cells. Cell lysates (500 mg of total protein) were immunoprecipitated with anti-Src monoclonal antibody (mAb327). Kinase assay of immunoprecipitates in the presence or absence of 10 mm BIPM and 1 mm NAM was performed at 301C for 15 min as described previously (Hamaguchi and Hanafusa, 1987) . Casein (upper panel) and Enolase (lower panel) were used as exogenous substrates for the kinase assay. (b) DSH2/SH3v-Src (5 mg) was transiently expressed in COS 7 cells and in vitro kinase assays were performed in the presence or absence of the SH-alkylating agents, 10 mm BIPM (upper panel) or 1 mm NAM (lower panel). DSH2/ SH3v-Src migrated slightly faster than enolase in 8% SDS-PAGE gel electrophoresis. Endogenous c-Src can be also observed in both panels. (c) In vitro kinase assay of C4Av-Src and C5Av-Src in the presence or absence of the SH-alkylating agents was performed as above. All these figures were representatives of three independent experiments suggest that, despite their location, Cys277 and Cys400 are dispensable for the inhibition by the SH-alkylating agents.
We next focused on the four mutants, C6A, C7A, C8A and C9A, in which one of the four cysteines in the CC motif located at the base of the C-terminal lobe of the kinase domain was replaced (Figure 1 ). Among the four mutants, C9Av-Src showed lower kinase activity compared with those of other three mutant Src proteins (Figure 3a proteins were sensitive to 10 mm BIPM and 1 mm NAM to the levels similar to those of wild-type v-Src (Figure 3a, left panel) .
In the CC motif, first two cysteine residues, Cys483 and Cys487, and latter two residues, Cys496 and Cys498, are closely located to each other. As observed in LMW-PTP (Chiarugi et al., 2001) , these paired cysteines might compensate their function each other because of their close localization. Therefore, we introduced double and quadruple mutations in these clustered cysteines. C67Av-src has substitution of cysteines at positions 483 and 487 to alanine in pair. C89Av-Src has substitutions of cysteines at 496 and 498. In C6-9Av-Src, all these four cysteines, Cys483, Cys487, Cys 496 and Cys498, were replaced to alanine. These mutants were transiently expressed in Cos7, immunoprecipitated and their kinase activity and sensitivity to the SH-alkylating agents were examined. As shown in Figure 3a (right panel), all of these mutant Src proteins have decreased kinase activity compared with that of wild-type v-Src. Although autophosphorylation of these mutant kinases were suppressed, they showed clear resistance to 10 mm BIPM or 1 mm NAM in the phosphorylation of exogenous substrates. Under the condition employed here, both C67Av-src and C89Av-Src retained around 80% of transphosphorylation activities of the exogenous substrates in the presence of the SH-alkylating agents. Similarly, the C6-9Av-Src kinase also showed resistance in the phosphorylation of exogenous substrates and almost 90% of the kinase activity was retained in the presence of the SHalkylating agents (Figure 3a , b, right panels). These results suggest that cysteine residues in the CC domain are critical for the inhibition by the SH-alkylating agents and modification of multiple, at least two, cysteines by the SH-alkylating agents were required for the inhibition. It is of interest that autophosphorylation of the double and quadruple mutants were sensitive to the SHalkylating agents. Our results suggest that regulation of autophosphorylation in Src might be differed from that of substrate phosphorylation.
Close to the CC motif, there is another cysteine residue at position 520 in v-Src (Figure 1) . We next examined the role of Cys520 for the inhibition of kinase activity by the SH-alkylating agents. In contrast to the mutants of the CC motif, C10Av-Src which has replacement of Cys520 to alanine was active in kinase to the level similar to that of wild-type v-Src. C10Av-Src was also sensitive in its autophosphorylation but showed clear resistance to 10 mm BIPM (Figure 3c , left panel) and 1 mm NAM (Figure 4c , left panel) in the phosphorylation of exogenous substrates.
To assess the combined function of Cys520 and cysteines in the CC motif, we constructed a mutant v-Src, C6-10Av-Src, in which Cys520 together with four cysteines in the CC motif were replaced with alanine. We compared the resistance of C6-10Av-Src to the SHalkylating agent with those of wild-type v-Src and C10Av-Src at a higher concentration of NAM (5 mm). As shown in Figure 3c (right panel), in the presence of 5 mm NAM, kinase activity of C10Av-Src was strongly suppressed to the level similar to that of wild-type v-Src. In contrast, C6-10Av-Src showed resistance to 5 mm NAM. These results suggest the important role of Cys520 in addition to those in the CC motif, for the inhibition of kinase activity by the SH-alkylating agents.
During the course of our study, we found clear difference between Cys520v-Src and other CC motif mutants in their transforming activity. Cells transformed with either C67Av-Src or C89Av-Src showed temperature sensitivity in the morphological transformation and tyrosine phosphorylation of cellular proteins as we previously reported (Senga et al., 2000) . In contrast, cells transformed with C10Av-Src did not temperature sensitivity (Figure 4a, b) . These results suggest that Cys520 is, at least in part, discrete from other CC motif mutants in its biological function.
Since c-Src lacks Cys520 (Figure 1) , we next compared the sensitivity of c-Src to the SH-alkylating agents with that of v-Src. As shown in Figure 4c , c-Src was relatively resistant to the inhibition by 1 mm NAM. To confirm these observations, we constructed a c-Src mutant, F520Cc-Src, in which cysteine was introduced at the position 520 instead of phenylalanine. Compared with wild-type c-Src, F520Cc-Src was much more sensitive to the inhibition by 1 mm NAM to the levels similar to those of wild-type v-Src (Figure 4c ). To extend these observations, we constructed another c-Src mutant, C6/9Ac-Src, in which Cys483 and Cys498 in the CC motif were replaced with alanines. While wild-type c-Src was sensitive to the inactivation by a higher concentration of NAM (5 mm), C6/9Ac-Src showed clear resistance to the high dose of NAM (Figure 4c, d) . These results suggest that cysteine residues in the CC motif of c-Src are also important for the regulation of its catalytic activity.
In this report, we showed evidence for the first time that among 10 cysteine residues in v-Src, four cysteines in the CC motif, Cys483, Cys487, Cys496 and Cys498, and another one in the end of the C-terminal lobe, Cys520, are important for the inhibition of catalytic activity by the SH-alkylating agents. Our results strongly suggest that inhibition of v-Src kinase activity by the SH-alkylating agents requires multiple cysteine residues, cysteine residues in the CC motif in addition to Cys520. In case of the CC motif, paired cysteine residues seemed to be mutually complementary so that at least two cysteines were required for the inhibition. In addition, Cys520 seems to be independently required for the inhibition of the kinase. It should be noted that mutation in two of cysteine residues in the CC motif resulted in the reduction of the catalytic activity, suggesting the functional importance of cysteine residues in the CC motif. In contrast to these cysteine residues, cysteines in the SH2 domain, Cys185, Cys238 and Cys245, were dispensable for the inhibition of the kinase, although two of them, Cys238 and Cys245, are highly conserved among the Src family tyrosine kinases. Similarly, Cys277 and Cys400 were dispensable for the inhibition by the SH-alkylating agents although they are localized in the catalytic cleft and highly conserved among the Src family tyrosine kinases (Figure 1 ). Of these two cysteines, Cys277 seems to be specifically important for the catalytic activity because of its location on a tip of the N-terminal lobe protruding to form the catalytic cleft (Xu et al., 1997) . However C4Av-Src mutated in Cys277 was active in kinase and sensitive to the SH-alkylating agents to the levels similar to those of wild-type v-Src, suggesting that modification of Cys277, even if exist, is not critical for the kinase activity.
Compared with v-Src, c-Src was relatively resistant to the SH-alkylating agents (Figure 4c ). The results with F520Cc-Src and C10Av-Src strongly suggest that the difference between v-Src and c-Src in their sensitivity to the SH-alkylating agents is mainly determined by the presence of cysteine residue at position 520. This, in turn suggests that the end of C-terminal lobe of c-Src is potentially important as well as that of v-Src for their catalytic activity although the amino-acid sequence around position 520 of c-Src is completely different from that of v-Src. Although c-Src was resistant to 1 mm NAM, it showed sensitivity to the higher concentration (5 mm) of NAM (Figure 4c ). However, C6/9Ac-Src showed resistance to 5 mm NAM, suggesting that the CC domain has important function for not only v-Src but also c-Src for their catalytic activity. Since the CC motif and Cys520 are located in the base of the C-terminal lobe, our results strongly suggest that, in addition to Tyr527 in the tail, this part of the C-terminal lobe may have allosteric inhibitory function to the catalytic activity. Experiments with DSH2/SH3v-Src suggest that repressor function of this region seems to be independent of SH2-pTyr527 and SH3-linker interactions. It is of interest that both Cys520 and the CC motif are overlapped with aH helix of the C-terminal lobe. In contrast, other cysteine residues including those in the SH2 domain and in the catalytic cleft are in the b sheets or associate with b sheets. However, it is not yet clear whether these difference in the secondary structure correlates with the inhibitory function of the CC motif and Cys520. Further study including the structural analysis of v-Src is necessary for the complete comprehension of the regulatory mechanism by the modification of the CC motif and Cys520.
